Biocryst Pharmaceuticals (Bioanalytical Laboratory Operations) is Other Pharmaceuticals and Biotechnology in United States that focus on development services business. They cover business area such as owner, operator, preclincal drug discovery, research and development service.
Other Pharmaceuticals and Biotechnology
-
Development Services
-
4505 Emperor Boulvard
Suite 200
Durham, NC 27703
United States
Private
owneroperatorpreclincal drug discoveryresearch and development service
* We use standard office opening hours in near Biocryst Pharmaceuticals (Bioanalytical Laboratory Operations)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Biocryst Pharmaceuticals (Bioanalytical Laboratory Operations) is Other Pharmaceuticals and Biotechnology business from United States that founded in - ( years old in ), Biocryst Pharmaceuticals (Bioanalytical Laboratory Operations) business is focusing on Development Services.
Biocryst Pharmaceuticals (Bioanalytical Laboratory Operations) headquarter office and corporate office address is located in 4505 Emperor Boulvard Suite 200 Durham, NC 27703 United States.
Biocryst Pharmaceuticals (Bioanalytical Laboratory Operations) was founded in United States.
In , Biocryst Pharmaceuticals (Bioanalytical Laboratory Operations) is currently focus on development services sector.
Above is snippet of Google Trends for "development services" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Biocryst Pharmaceuticals (Bioanalytical Laboratory Operations), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
